| 000 | 00851 a2200217 4500 | ||
|---|---|---|---|
| 005 | 20250517091204.0 | ||
| 264 | 0 | _c20160411 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1424-8247 | ||
| 024 | 7 |
_a10.3390/ph9010012 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEmadi, Ashkan | |
| 245 | 0 | 0 |
_aMinimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah's Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia. _h[electronic resource] |
| 260 |
_bPharmaceuticals (Basel, Switzerland) _cMar 2016 |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aBade, Najeebah A | |
| 700 | 1 | _aStevenson, Brandi | |
| 700 | 1 | _aSingh, Zeba | |
| 773 | 0 |
_tPharmaceuticals (Basel, Switzerland) _gvol. 9 _gno. 1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3390/ph9010012 _zAvailable from publisher's website |
| 999 |
_c25911667 _d25911667 |
||